Around the world, 4.3 million people die prematurely from cancer. Over the last seven years, UICC has united the cancer community to position cancer on the global health and development agenda, with inclusion of cancer and non-communicable diseases in the Sustainable Development Goals (SDGs) in 2015 and culminating in the successful adoption of a cancer resolution at the World Health Assembly in 2017. However, as we endeavour to stimulate universal health coverage and global equity, between and within countries, to successfully meet our targets of a 25% reduction in cancer mortality by 2025 and a 33% reduction by 2030, global commitments must be translated into national action.
‘Treatment for All’ is the name of a new, bold and inspiring advocacy initiative run by UICC. It calls on the international cancer community to address the global equity gap in access to cancer services by getting behind four essential pillars of cancer treatment and care:
UICC members can identify priorities under Treatment for All that best fit their national needs and strategies. Additionally, as part of this initiative, UICC aspires to engage two sets of 20 low- and middle-income countries in a comprehensive, guided process of their own Treatment for All campaigns, working to improve the provision of information, availability and access to cancer services for whole-of-population progress.
No matter where each country stands, or which inequities each country faces, Treatment for All captures the importance of addressing all cancers, for all ages, across all geographies in order to improve patient outcomes with cost-effective, timely and quality treatment and care, and without bias. We urge all UICC members to take action toward Treatment for All.
This initiative will kick into action in 2018. Contact email@example.com to learn how your organisation can get involved. Please note that we cannot provide individual aid to patients or their families. If you are seeking local support, please view our Map of Members to find organisations in your area.
Rising health-care costs overall, and health care costs related to cancer and other NCDs, present an important challenge for national governments. Investments in cancer control are often minimal, fragmented or unbalanced across the cancer control continuum. However, there is now far greater awareness of the costs of inaction on both the economy of countries and in health terms. For instance, it has been estimated that investing just USD 11.4 billion in a set of core prevention strategies in LMICs can result in a saving of up to USD 100 billion in cancer treatment costs.
There are a growing number of examples of interventions that are both cost effective and impact national cancer incidence and mortality. Consequently, the scale up of these ‘best practice’ policies, programmes and services to reduce cancer illness and death is possible across resource settings and can deliver a significant return on investment, allowing governments to justify placing cancer control at the heart of their national health plans.
UICC is currently working with WHO and NCDA on a high-level investment case on NCDs, including examples from across the cancer control continuum of prevention through to treatment, palliative care and rehabilitation, accompanied by country case studies.